Cardiogenic Shock Post Myocardial Infarction
6
2
2
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (6)
Safety and Efficacy of FAP iCDC in Acute Myocardial Infarction With Cardiogenic Shock
Prognosis of Patients With Mixed Cardiogenic-Vasoplegic Shock
Hong Kong Cardiogenic Shock Initiative
Prospective Validation of the STOPSHOCK Score - Artificial Intelligence Based Predictive Scoring System to Identify the Risk of Developing Cardiogenic Shock (CS) in Patients Suffering From Acute Coronary Syndrome (ACS)
Early Beta Blocker Administration in STEMI Patients With SCAI B Status
Comparison of Central Venous Oxygen Saturation Measurements by Non-invasive Mespere Venous Oximeter and Central Venous Catheter